Craig Haifer

736 total citations · 1 hit paper
25 papers, 405 citations indexed

About

Craig Haifer is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Craig Haifer has authored 25 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 11 papers in Infectious Diseases and 10 papers in Molecular Biology. Recurrent topics in Craig Haifer's work include Clostridium difficile and Clostridium perfringens research (10 papers), Gut microbiota and health (9 papers) and Inflammatory Bowel Disease (7 papers). Craig Haifer is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (10 papers), Gut microbiota and health (9 papers) and Inflammatory Bowel Disease (7 papers). Craig Haifer collaborates with scholars based in Australia, United States and Singapore. Craig Haifer's co-authors include Rupert W. Leong, Sudarshan Paramsothy, Thomas J. Borody, Nadeem O. Kaakoush, Laurence Don Wai Luu, Simon Ghaly, Tao Yang, Siddharth Sood, Peter Angus and Adam Testro and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Craig Haifer

20 papers receiving 400 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial

2021 200 citations Craig Haifer, Sudarshan Paramsothy et al. The Lancet. Gastroenterology & hepatology profile →

Peers

Craig Haifer

EPIDE

GENET

GASTR

Aditya Bajaj India

Jan Březina Czechia

David Busquets Spain

Winnie H. Sim Australia

J. Landy United Kingdom

Elizabeth K. Broussard United States

Andrew Joelson United States

Romain Bouziat United States

Sina Marsilio United States

Derrick Tee Australia

Aditya Bajaj India

Craig Haifer

166 ×0.7

101 ×0.5

85 ×0.6

EPIDE

138 ×1.4

GENET

64 ×0.8

GASTR

Citations per year, relative to Craig Haifer Craig Haifer (= 1×) peers Aditya Bajaj

Countries citing papers authored by Craig Haifer

Since Specialization

Citations

This map shows the geographic impact of Craig Haifer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Haifer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Haifer more than expected).

Fields of papers citing papers by Craig Haifer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Haifer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Haifer. The network helps show where Craig Haifer may publish in the future.

Co-authorship network of co-authors of Craig Haifer

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Haifer. A scholar is included among the top collaborators of Craig Haifer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Haifer. Craig Haifer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bryant, Robert V., Samuel P. Costello, Alice S. Day, et al.. (2025). Translational strategies for oral delivery of faecal microbiota transplantation. Gut. 74(12). 2096–2117. 5 indexed citations

Costello, Samuel P., Robert V. Bryant, Sarah Haylock‐Jacobs, et al.. (2025). A study protocol for a double-blinded, randomised, placebo-controlled trial on the use of encapsulated FMT for reducing the side effects of HSCT: the HSCT-BIOME study. BMC Cancer. 25(1). 656–656.

Majzoub, Marwan E., Craig Haifer, Sudarshan Paramsothy, et al.. (2025). Bacterial taxonomic and functional changes following oral lyophilized donor fecal microbiota transplantation in patients with ulcerative colitis. mSystems. 10(10). e0099125–e0099125.

Majzoub, Marwan E., Sudarshan Paramsothy, Craig Haifer, et al.. (2024). The phageome of patients with ulcerative colitis treated with donor fecal microbiota reveals markers associated with disease remission. Nature Communications. 15(1). 8979–8979. 8 indexed citations

Haifer, Craig, et al.. (2024). Faecal transplantation: the good, the bad and the ugly. Internal Medicine Journal. 55(1). 35–40.

Paramsothy, Sudarshan, Viraj C. Kariyawasam, Ramesh Paramsothy, et al.. (2024). Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled Trial. Clinical Gastroenterology and Hepatology. 22(11). 2299–2308.e5. 8 indexed citations

Majzoub, Marwan E., Laurence Don Wai Luu, Craig Haifer, et al.. (2024). Refining microbial community metabolic models derived from metagenomics using reference-based taxonomic profiling. mSystems. 9(9). e0074624–e0074624. 1 indexed citations

Paramsothy, Sudarshan, Viraj C. Kariyawasam, Ramesh Paramsothy, et al.. (2023). 1029 WITHDRAWAL VERSUS CONTINUATION OF THIOPURINE IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS (VIEWS): A MULTI-CENTRE RANDOMISED CONTROLLED TRIAL. Gastroenterology. 164(6). S–221. 2 indexed citations

Fung, Caroline, Viraj C. Kariyawasam, Ramesh Paramsothy, et al.. (2022). IDDF2022-ABS-0162 Histological remission using a nancy index of 0 is associated with longer relapse-free survival than histological activity in patients with ulcerative colitis in clinical and endoscopic remission. A149.2–A149.

10.

Haifer, Craig, Laurence Don Wai Luu, Sudarshan Paramsothy, et al.. (2022). Microbial determinants of effective donors in faecal microbiota transplantation for UC. Gut. 72(1). 90–100. 34 indexed citations

11.

Haifer, Craig, Sudarshan Paramsothy, Nadeem O. Kaakoush, et al.. (2021). Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial. The Lancet. Gastroenterology & hepatology. 7(2). 141–151. 200 indexed citations breakdown →

12.

Haifer, Craig, Rupert W. Leong, & Sudarshan Paramsothy. (2020). The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease. Current Opinion in Pharmacology. 55. 8–16. 22 indexed citations

13.

Haifer, Craig, Ashish Srinivasan, S. Menon, et al.. (2019). Switching Australian patients with moderate to severe inflammatory bowel disease from originator infliximab to biosimilar Inflectra: Interim results from a multicenter parallel cohort study. Journal of Gastroenterology and Hepatology. 34. 155–156. 2 indexed citations

14.

Kariyawasam, Viraj C., et al.. (2019). Safety of drugs used for the treatment of Crohn’s disease. Expert Opinion on Drug Safety. 18(5). 357–367. 23 indexed citations

15.

Haifer, Craig, Ian C. Lawrance, Michael W. Clarke, et al.. (2019). Vitamin D metabolites are lower with active Crohn’s disease and spontaneously recover with development of remission. Therapeutic Advances in Gastroenterology. 12. 3973054008–3973054008. 1 indexed citations

16.

Chan, Webber, Nicole Lynch, Peter A. Bampton, et al.. (2018). Entyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel disease. European Journal of Gastroenterology & Hepatology. 30(7). 735–740. 6 indexed citations

17.

Chan, Webber, Hang Hock Shim, Siew C. Ng, et al.. (2018). A Global Survey of Gastroenterologists’ Travel Advice to Patients with Inflammatory Bowel Disease on Immunosuppressive Agents and Management of Those Visiting Tuberculosis-Endemic Areas. Journal of Crohn s and Colitis. 12(11). 1261–1269. 3 indexed citations

18.

Sood, Siddharth, Craig Haifer, Lijia Yu, et al.. (2018). Early viral‐specific T‐cell testing predicts late cytomegalovirus reactivation following liver transplantation. Transplant Infectious Disease. 20(5). e12934–e12934. 11 indexed citations

19.

Ip, Matthew H., et al.. (2018). Expert-led didactic versus self-directed audiovisual training of confocal laser endomicroscopy in evaluation of mucosal barrier defects. SHILAP Revista de lepidopterología. 6(1). E115–E122. 1 indexed citations

20.

Sood, Siddharth, Craig Haifer, Lijia Yu, et al.. (2017). A novel immune function biomarker identifies patients at risk of clinical events early following liver transplantation. Liver Transplantation. 23(4). 487–497. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact